John L. Green - Net Worth and Insider Trading
John L. Green Net Worth
The estimated net worth of John L. Green is at least $36,528 dollars as of 2024-12-01. John L. Green is the CFO of Cogent Biosciences Inc and owns about 3,841 shares of Cogent Biosciences Inc (COGT) stock worth over $36,528. Details can be seen in John L. Green's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John L. Green has not made any transactions after 2021-04-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John L. Green
John L. Green Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John L. Green owns 2 companies in total, including Cogent Biosciences Inc (COGT) , and Merrimack Pharmaceuticals Inc (MACK) .
Click here to see the complete history of John L. Green’s form 4 insider trades.
Insider Ownership Summary of John L. Green
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
COGT | Cogent Biosciences Inc | 2021-04-26 | Chief Financial Officer |
MACK | Merrimack Pharmaceuticals Inc | 2017-06-14 | Principal Accounting Officer |
John L. Green Latest Holdings Summary
John L. Green currently owns a total of 1 stock. John L. Green owns 3,841 shares of Cogent Biosciences Inc (COGT) as of April 26, 2021, with a value of $36,528.
Latest Holdings of John L. Green
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
COGT | Cogent Biosciences Inc | 2021-04-26 | 3,841 | 9.51 | 36,528 |
Holding Weightings of John L. Green
John L. Green Form 4 Trading Tracker
According to the SEC Form 4 filings, John L. Green has made a total of 1 transactions in Cogent Biosciences Inc (COGT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cogent Biosciences Inc is the sale of 17,813 shares on April 26, 2021, which brought John L. Green around $157,823.
Insider Trading History of John L. Green
- 1
John L. Green Trading Performance
John L. Green Ownership Network
John L. Green Owned Company Details
What does Cogent Biosciences Inc do?
Who are the key executives at Cogent Biosciences Inc?
John L. Green is the Chief Financial Officer of Cogent Biosciences Inc. Other key executives at Cogent Biosciences Inc include 10 percent owner & other: See Remarks Fairmount Funds Management Llc , Chief Legal Officer Evan Kearns , and Chief Scientific Officer John Edward Robinson .
Cogent Biosciences Inc (COGT) Insider Trades Summary
Over the past 18 months, John L. Green made no insider transaction in Cogent Biosciences Inc (COGT). Other recent insider transactions involving Cogent Biosciences Inc (COGT) include a net purchase of 800,000 shares made by Fairmount Funds Management Llc ,
In summary, during the past 3 months, insiders sold 0 shares of Cogent Biosciences Inc (COGT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cogent Biosciences Inc (COGT) were sold and 800,000 shares were bought by its insiders, resulting in a net purchase of 800,000 shares.
Cogent Biosciences Inc (COGT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cogent Biosciences Inc Insider Transactions
John L. Green Mailing Address
Above is the net worth, insider trading, and ownership report for John L. Green. You might contact John L. Green via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.